Order Article Reprints

Wang S-Y, Wu C-E, Lai C-C, Chen J-S, Tsai C-Y, Cheng C-T, Yeh T-S, Yeh C-N. Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome. Cancers. 2019; 11(3):424. https://doi.org/10.3390/cancers11030424

Wang, Shang-Yu, Chiao-En Wu, Chun-Chi Lai, Jen-Shi Chen, Chun-Yi Tsai, Chi-Tung Cheng, Ta-Sen Yeh, and Chun-Nan Yeh. 2019. "Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome" Cancers 11, no. 3: 424. https://doi.org/10.3390/cancers11030424

Wang, S.-Y., Wu, C.-E., Lai, C.-C., Chen, J.-S., Tsai, C.-Y., Cheng, C.-T., Yeh, T.-S., & Yeh, C.-N. (2019). Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome. Cancers, 11(3), 424. https://doi.org/10.3390/cancers11030424